Inflammatory Bowel Disease Therapeutic Target

This is a news story, published by ScienceDaily, that relates primarily to Charité -- Universitätsmedizin Berlin news.

disease research news

For more disease research news, you can click here:

more disease research news

ScienceDaily news

For more news from ScienceDaily, you can click here:

more news from ScienceDaily

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about

chronic inflammatory bowel diseases

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest inflammatory bowel disease news, common chronic inflammatory bowel diseases news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Chronic inflammatory bowel disease

ScienceDaily

•

Health

Preventing chronic inflammation from turning into cancer

Summary

Nutrition label

76% Informative

Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of bowel cancer.

Researchers at Charité -- Universitätsmedizin Berlin have now discovered a therapeutic target that significantly contributes to halting the ongoing inflammatory processes.

Ongoing inflammation can cause lasting tissue damage and increase the risk of cancer.

Chronic inflammation does not always lead to bowel cancer, and not every patient is affected in the same way.

Researchers found a particularly high number of receptors for the messenger molecule oncostatin M around the tumors in tissue samples from patients with colorectal cancer caused by chronic intestinal inflammation.

This observation suggests that this signaling pathway may help promote cancer development.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech